Krios I-Titan Krios I at Diamond
|
Diamond Proposal Number(s):
[20223, 21004]
Open Access
Abstract: Tumor-suppressor let-7 pre-microRNAs (miRNAs) are regulated by terminal uridylyltransferases TUT7 and TUT4 that either promote let-7 maturation by adding a single uridine nucleotide to the pre-miRNA 3′ end or mark them for degradation by the addition of multiple uridines. Oligo-uridylation is increased in cells by enhanced TUT7/4 expression and especially by the RNA-binding pluripotency factor LIN28A. Using cryogenic electron microscopy, we captured high-resolution structures of active forms of TUT7 alone, of TUT7 plus pre-miRNA and of both TUT7 and TUT4 bound with pre-miRNA and LIN28A. Our structures reveal that pre-miRNAs engage the enzymes in fundamentally different ways depending on the presence of LIN28A, which clamps them onto the TUTs to enable processive 3′ oligo-uridylation. This study reveals the molecular basis for mono- versus oligo-uridylation by TUT7/4, as determined by the presence of LIN28A, and thus their mechanism of action in the regulation of cell fate and in cancer.
|
Jul 2024
|
|
Krios I-Titan Krios I at Diamond
Krios II-Titan Krios II at Diamond
|
Pablo
Alcon
,
Artur P.
Kaczmarczyk
,
Korak Kumar
Ray
,
Themistoklis
Liolios
,
Guillaume
Guilbaud
,
Tamara
Sijacki
,
Yichao
Shen
,
Stephen H.
Mclaughlin
,
Julian E.
Sale
,
Puck
Knipscheer
,
David S.
Rueda
,
Lori A.
Passmore
Diamond Proposal Number(s):
[23268, 31336]
Open Access
Abstract: DNA crosslinks block DNA replication and are repaired by the Fanconi anaemia pathway. The FANCD2–FANCI (D2–I) protein complex is central to this process as it initiates repair by coordinating DNA incisions around the lesion1. However, D2–I is also known to have a more general role in DNA repair and in protecting stalled replication forks from unscheduled degradation2,3,4. At present, it is unclear how DNA crosslinks are recognized and how D2–I functions in replication fork protection. Here, using single-molecule imaging, we show that D2–I is a sliding clamp that binds to and diffuses on double-stranded DNA. Notably, sliding D2–I stalls on encountering single-stranded–double-stranded (ss–ds) DNA junctions, structures that are generated when replication forks stall at DNA lesions5. Using cryogenic electron microscopy, we determined structures of D2–I on DNA that show that stalled D2–I makes specific interactions with the ss–dsDNA junction that are distinct from those made by sliding D2–I. Thus, D2–I surveys dsDNA and, when it reaches an ssDNA gap, it specifically clamps onto ss–dsDNA junctions. Because ss–dsDNA junctions are found at stalled replication forks, D2–I can identify sites of DNA damage. Therefore, our data provide a unified molecular mechanism that reconciles the roles of D2–I in the recognition and protection of stalled replication forks in several DNA repair pathways.
|
Jul 2024
|
|
Krios I-Titan Krios I at Diamond
|
Diamond Proposal Number(s):
[19832]
Abstract: Most healthy people carry bacteria-infecting viruses called crassviruses in their gut, which may help to maintain the gut microbiome. However, scientists know little about this group of viruses, including their structure. This led researchers at the University of York to visit the electron Bio-Imaging Centre (eBIC) at Diamond Light Source where they captured images of these elusive viruses for the first time. Using high-voltage cryo-electron microscopes at eBIC, they overcame challenges posed by these large virus assemblies, resolving their structure to a near-atomic resolution. They found that the virus consists of a “head” region that stores viral DNA and proteins. The head is connected to a “tail” that injects these contents into bacteria, allowing virus replication to take place inside microbial cells. Additionally, they discovered a muzzle that prevents DNA and proteins from leaking out through the tail. A never-before-seen “crass” fold was spotted in the tail that the team hypothesised loosens and tightens the muzzle to control the flow of viral material into the bacterium. This study, published in Nature, offers a first glimpse at an underexplored family of widespread viruses and provides insight into their lifecycle.
|
Jul 2024
|
|
Krios I-Titan Krios I at Diamond
Krios II-Titan Krios II at Diamond
|
Alexander T.
Bakker
,
Ioli
Kotsogianni
,
Mariana
Avalos
,
Jeroen M.
Punt
,
Bing
Liu
,
Diana
Piermarini
,
Berend
Gagestein
,
Cornelis J.
Slingerland
,
Le
Zhang
,
Joost J.
Willemse
,
Leela B.
Ghimire
,
Richard J. H. B. N.
Van Den Berg
,
Antonius P. A.
Janssen
,
Tom H. M.
Ottenhoff
,
Constant A. A.
Van Boeckel
,
Gilles P.
Van Wezel
,
Dmitry
Ghilarov
,
Nathaniel I.
Martin
,
Mario
Van Der Stelt
Diamond Proposal Number(s):
[33054]
Open Access
Abstract: Bacteria have evolved resistance to nearly all known antibacterials, emphasizing the need to identify antibiotics that operate via novel mechanisms. Here we report a class of allosteric inhibitors of DNA gyrase with antibacterial activity against fluoroquinolone-resistant clinical isolates of Escherichia coli. Screening of a small-molecule library revealed an initial isoquinoline sulfonamide hit, which was optimized via medicinal chemistry efforts to afford the more potent antibacterial LEI-800. Target identification studies, including whole-genome sequencing of in vitro selected mutants with resistance to isoquinoline sulfonamides, unanimously pointed to the DNA gyrase complex, an essential bacterial topoisomerase and an established antibacterial target. Using single-particle cryogenic electron microscopy, we determined the structure of the gyrase–LEI-800–DNA complex. The compound occupies an allosteric, hydrophobic pocket in the GyrA subunit and has a mode of action that is distinct from the clinically used fluoroquinolones or any other gyrase inhibitor reported to date. LEI-800 provides a chemotype suitable for development to counter the increasingly widespread bacterial resistance to fluoroquinolones.
|
Jun 2024
|
|
Krios I-Titan Krios I at Diamond
|
Diamond Proposal Number(s):
[18258]
Open Access
Abstract: Amongst the major types of archaeal filaments, several have been shown to closely resemble bacterial homologues of the Type IV pili (T4P). Within Sulfolobales, member species encode for three types of T4P, namely the archaellum, the UV-inducible pilus system (Ups) and the archaeal adhesive pilus (Aap). Whereas the archaellum functions primarily in swimming motility, and the Ups in UV-induced cell aggregation and DNA-exchange, the Aap plays an important role in adhesion and twitching motility. Here, we present a cryoEM structure of the Aap of the archaeal model organism Sulfolobus acidocaldarius. We identify the component subunit as AapB and find that while its structure follows the canonical T4P blueprint, it adopts three distinct conformations within the pilus. The tri-conformer Aap structure that we describe challenges our current understanding of pilus structure and sheds new light on the principles of twitching motility.
|
Jun 2024
|
|
Krios I-Titan Krios I at Diamond
|
Open Access
Abstract: RNA-based therapeutics, including siRNA, have obtained recognition in recent years due to their potential to treat various chronic and rare diseases. However, there are still limitations to lipid-based drug delivery systems in the clinical use of RNA therapeutics due to the need for optimization in the design and the preparation process. In this study, we propose adaptive focused ultrasound (AFU) as a drug loading technique to protect RNA from degradation by encapsulating small RNA in nanoliposomes, which we term nanoplexes. The AFU method is non-invasive and isothermal, as nanoplexes are produced without direct contact with any external materials while maintaining precise temperature control according to the desired settings. The controllability of sample treatments can be effectively modulated, allowing for a wide range of ultrasound intensities to be applied. Importantly, the absence of co-solvents in the process eliminates the need for additional substances, thereby minimizing the potential for cross-contaminations. Since AFU is a non-invasive method, the entire process can be conducted under sterile conditions. A minimal volume (300 μL) is required for this process, and the treatment is speedy (10 min in this study). Our in vitro experiments with silencer CD44 siRNA, which performs as a model therapeutic drug in different mammalian cell lines, showed encouraging results (knockdown > 80%). To quantify gene silencing efficacy, we employed quantitative polymerase chain reaction (qPCR). Additionally, cryo-electron microscopy (cryo-EM) and atomic force microscopy (AFM) techniques were employed to capture images of nanoplexes. These images revealed the presence of individual nanoparticles measuring approximately 100–200 nm in contrast with the random distribution of clustered complexes observed in ultrasound-untreated samples of liposome nanoparticles and siRNA. AFU holds great potential as a standardized liposome processing and loading method because its process is fast, sterile, and does not require additional solvents.
|
Jun 2024
|
|
Krios I-Titan Krios I at Diamond
Krios II-Titan Krios II at Diamond
Krios IV-Titan Krios IV at Diamond
|
Diamond Proposal Number(s):
[19713, 30932]
Open Access
Abstract: Transposases drive chromosomal rearrangements and the dissemination of drug-resistance genes and toxins1,2,3. Although some transposases act alone, many rely on dedicated AAA+ ATPase subunits that regulate site selectivity and catalytic function through poorly understood mechanisms. Using IS21 as a model transposase system, we show how an ATPase regulator uses nucleotide-controlled assembly and DNA deformation to enable structure-based site selectivity, transposase recruitment, and activation and integration. Solution and cryogenic electron microscopy studies show that the IstB ATPase self-assembles into an autoinhibited pentamer of dimers that tightly curves target DNA into a half-coil. Two of these decamers dimerize, which stabilizes the target nucleic acid into a kinked S-shaped configuration that engages the IstA transposase at the interface between the two IstB oligomers to form an approximately 1 MDa transpososome complex. Specific interactions stimulate regulator ATPase activity and trigger a large conformational change on the transposase that positions the catalytic site to perform DNA strand transfer. These studies help explain how AAA+ ATPase regulators—which are used by classical transposition systems such as Tn7, Mu and CRISPR-associated elements—can remodel their substrate DNA and cognate transposases to promote function.
|
Jun 2024
|
|
Krios I-Titan Krios I at Diamond
|
Diamond Proposal Number(s):
[33797]
Open Access
Abstract: Model membranes allow for structural and biophysical studies on membrane biochemistry at the molecular level, albeit on systems of reduced complexity which can limit biological accuracy. Floating supported bilayers offer a means of producing planar lipid membrane models not adhered to a surface, which allows for improved accuracy compared to other model membranes. Here we communicate the incorporation of an integral membrane protein complex, the multidomain β-barrel assembly machinery (Bam), into our recently developed in situ self-assembled floating supported bilayers. Using neutron reflectometry and quartz crystal microbalance measurements we show this sample system can be fabricated using a two-step self-assembly process. We then demonstrate the complexity of the model membrane and tuneability of the membrane-to-surface distance using changes in the salt concentration of the bulk solution. Results demonstrate an easily fabricated, biologically accurate and tuneable membrane assay system which can be utilized for studies on integral membrane proteins within their native lipid matrix.
|
Jun 2024
|
|
Krios I-Titan Krios I at Diamond
|
Abstract: Transposition encompasses a range of biological processes in which a DNA segment can move between different genomic locations using enzymes called transposases. This ubiquitous process can cause mutations in the host genome, drive chromosomal rearrangements and the dissemination of drug-resistance genes and toxins. Transposition must be carefully regulated to minimize harm to the host and prevent deleterious DNA breaks. Numerous families of transposases rely on dedicated AAA+ ATPases that regulate both target selectivity and catalytic function. Nevertheless, the molecular mechanisms that these proteins use are still poorly understood. In this work we use the streamlined IS21 transposon as a model system in an attempt to shed light on these questions. Besides being a particularly widespread transposable element, IS21 codifies only two proteins: the transposase (IstA) and an essential regulatory ATPase (IstB). Using cryo-EM we show that the IstB ATPase self-assembles into a pentamer-of-dimers in a nucleotide-dependent fashion. IstB employs dedicated N-terminal domains to adopt an autoinhibited configuration that binds target DNA in an atypical way, introducing an overall 1800 bend onto it. Subsequent cryo-EM study of the complexes formed by IstB and the IstA transposase show that these IstB decamers are able to further dimerize to enforce an S-shape on the target DNA and form a landing pad for IstA transposase bound to the IS21 transposon ends. Specific protein-protein interactions activate the ATPase activity of IstB, remodelling the IstA-proximal nucleotide binding pockets. Furthermore, interaction with IstB enforces a marked conformational change on IstA, from the previously described intertwined plectoneme, to an open scissor-shaped configuration. The remodelling of the transposase positions the catalytic sites with an adequate geometry to perform the strand- transfer reaction. Preliminary single-molecule experiments provided further information into the DNA deformation caused by IstB and the kinetics of the transposition reaction. These results reveal how both proteins mutually activate each other, allowing us to propose a model for IS21 transposition, and drawing similarities and differences with related transposable elements to show how an ATPase-regulator uses nucleotide-controlled assembly and DNA deformation to enable site selectivity, transposase recruitment/activation, and integration. These studies help explain how AAA+ ATPase regulators – which are used by classic transposition systems such as Tn7, Mu, and CRISPR-associated elements– can remodel their substrate DNA and cognate transposases to perform their function.
|
May 2024
|
|
Krios I-Titan Krios I at Diamond
Krios II-Titan Krios II at Diamond
Krios III-Titan Krios III at Diamond
|
Diamond Proposal Number(s):
[28549, 15624, 16822, 16023, 21809]
Abstract: Tankyrase is an important protein that regulates a wide range of processes relevant to cancer and other conditions, such as diabetes, neurodegeneration and fibrosis. It supports 'Wnt signalling', essential for cell division and development and maintaining stem cells. Tankyrase also controls other cell functions critical to cancer, including the maintenance of telomeres at the end of chromosomes. Therefore, tankyrase has received substantial attention as a potential drug target.
|
May 2024
|
|